D De Bacquer
Overview
Explore the profile of D De Bacquer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
3209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jennings C, Astin F, Prescott E, Hansen T, Gale Chris P, De Bacquer D
Eur J Cardiovasc Nurs
. 2022 Nov;
22(7):719-729.
PMID: 36351004
Aims: To (1) Describe the sociodemographic and risk factor profiles of a sample of patients with coronary disease, (2) Explore associations between illness perceptions and health literacy with sociodemographic characteristics...
2.
Fraeyman N, De Bacquer D, Fiers T, Godderis L, Verhaeghe R, Eeckloo K, et al.
Acta Clin Belg
. 2022 Jun;
78(2):128-134.
PMID: 35703157
Introduction: Obesity is associated with a number of chronic diseases such as cardiovascular diseases and cancers. The association of obesity with occupational accidents has been suggested although the evidence is...
3.
Dewulf M, De Bacquer D, Muysoms F
Hernia
. 2022 Jan;
26(4):1211-1212.
PMID: 35044546
No abstract available.
4.
Snaterse M, Deckers J, Lenzen M, Jorstad H, De Bacquer D, Peters R, et al.
Int J Cardiol
. 2018 Mar;
258:1-6.
PMID: 29544918
Objective: We investigated smoking cessation rates in coronary heart disease (CHD) patients throughout Europe; current and as compared to earlier EUROASPIRE surveys, and we studied characteristics of successful quitters. Methods:...
5.
Kestelyn P, Kestelyn P, De Bacquer D, Stevens A
Int Ophthalmol
. 2017 Dec;
39(1):105-109.
PMID: 29274019
Purpose: To validate the hypothesis that BAK induces low-grade inflammation in the anterior chamber, we designed a study to investigate whether switching from BAK-preserved to preservative-free latanoprost in patients with...
6.
Vandecasteele S, De Bacquer D, Caluwe R, Ombelet S, Van Vlem B
Clin Microbiol Infect
. 2017 Jun;
24(1):65-71.
PMID: 28559003
Objective: To benchmark the immunogenicity of pneumococcal conjugated vaccine (PCV-13) versus pneumococcal polysaccharide vaccine (PPV-23) in haemodialysis patients pre-vaccinated or not with PPV-23. Methods: The study is a longitudinal quasi-experimental...
7.
Van der Heyden J, Charafeddine R, De Bacquer D, Tafforeau J, Van Herck K
BMC Med Res Methodol
. 2016 Aug;
16(1):98.
PMID: 27528010
Background: The Health Care Module of the European Health Interview Survey (EHIS) is aimed to obtain comparable information on the use of inpatient and ambulatory care in all EU member...
8.
Janssens H, Clays E, Fiers T, Verstraete A, De Bacquer D, Braeckman L
Occup Med (Lond)
. 2016 Aug;
67(2):114-120.
PMID: 27515972
Background: Measurement of hair cortisol concentration (HCC) may be used as a biomarker for chronic stress. However, the association between stress and HCC has rarely been investigated in a working...
9.
Reiner Z, De Backer G, Fras Z, Kotseva K, Tokgozoglu L, Wood D, et al.
Atherosclerosis
. 2016 Jan;
246:243-50.
PMID: 26812002
Objective: Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes significant reduction in morbidity and mortality, particularly in patients...
10.
Hermans M, De Bacquer D, De Block C, Truyers C, Vankeirsbilck A, De Backer G
Rev Med Liege
. 2014 Jun;
69(4):200-9.
PMID: 24923100
Cardiovascular disease (CVD) is the main cause of premature mortality in Europe. The burden of CVD could be reduced by controlling the major modifiable CVD risk factors (dyslipidaemia, arterial hypertension,...